Genmab — Juli 2020
-
Tagrisso med BTD og stærke data https://finance.yahoo.com/news/tagrisso-granted-breakthrough-therapy-designation-134700763.html Amivantamab skal virkelig vise resultater....
-
29/7 17:04
af Klarussen: Det er ikke godt hvis man går og frygter det ene eller det andet. Ikke for at spille kloge Åge. Men når man bestltter sig for at investere i en aktie bør man samtidig have besluttet sig for en game / business plan. Det være sig stop loss, gevinsthjemtagning, evt. short i SP500 hvis det hele krakker eller hvad man nu sover bedst med
-
Det var mest dette studie jeg tænker på https://www.clinicaltrials.gov/ct2/show/NCT04487080?recrs=ab&cond=Lung+Cancer&sfpd_s=07%2F16%2F2020&sfpd_d=14&sel_rss=new14 som der blev linket til i går.
-
God morgen.
-
God morgen
-
British Journal of Haematology -
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16980 -
New Topline TEPEZZA
(teprotumumab-trbw) Data Underscore its Efficacy in Longer Disease Duration, Long-Term Durability and Potential for Retreatment in People Living with Thyroid Eye Disease (TED) https://apnews.com/792e5d2d37194348be8940fa297fcd30 -
En særmeddelelse: https://www.proinvestor.com/boards/85475
-
Tillykke Helge!!:-)
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind